SCHEMBL18830345

SCHEMBL18830345

COc1ccc(-n2nnc3cnc(NC4CCC(N)CC4)nc32)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ MAPK6 Q16659 13/20 1.00
▸ GSK3A P49840 1/20 0.60
▸ GSK3B P49841 1/20 0.60
▸ EIF2AK4 Q9P2K8 2/20 0.56
▸ CDK7 P50613 1/20 0.46
▸ CDK9 P50750 1/20 0.46
▸ MAPK8 P45983 3/20 0.46
▸ MAPK10 P53779 3/20 0.46
▸ MAPK9 P45984 2/20 0.46
▸ CCNE1 P24864 1/20 0.46
▸ CDK2 P24941 1/20 0.46
▸ MAPK14 Q16539 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16011970 1.00 MAPK6 (1.00) MAPK6GSK3AGSK3BEIF2AK4CDK7
SCHEMBL16011969 1.00 MAPK6 (1.00) MAPK6GSK3AGSK3BEIF2AK4CDK7
SCHEMBL16012025 1.00 MAPK6 (1.00) MAPK6GSK3AGSK3BEIF2AK4CDK7
SCHEMBL16012215 0.95 MAPK6 (0.90) MAPK6GSK3AGSK3BEIF2AK4
SCHEMBL16012287 0.94 MAPK6 (1.00) MAPK6GSK3AGSK3BEIF2AK4
SCHEMBL16012108 0.94 MAPK6 (1.00) MAPK6GSK3AGSK3BEIF2AK4
SCHEMBL16012110 0.94 MAPK6 (1.00) MAPK6GSK3AGSK3BEIF2AK4
SCHEMBL16012286 0.94 MAPK6 (1.00) MAPK6GSK3AGSK3BEIF2AK4
SCHEMBL16012109 0.94 MAPK6 (1.00) MAPK6GSK3AGSK3BEIF2AK4
Hydrochloric Acid SCHEMBL16011966 0.93 MAPK6 (0.98) MAPK6GSK3AGSK3BEIF2AK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2964649-B1 TRIAZOLO[4,5-D]PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF DISEASES SUCH AS CANCER MERCK PATENT GMBH (DE) 2017-05-10 — — EP disclosed
Send feedback